Drug Shortage Report for CEFAZOLIN FOR INJECTION

Last updated on 2021-08-12 History
Report ID 88566
Drug Identification Number 02437120
Brand name CEFAZOLIN FOR INJECTION
Common or Proper name CEFAZOLIN FOR INJECTION
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) CEFAZOLIN
Strength(s) 10G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 VIALS
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-07-08
Estimated end date
Actual end date 2020-01-31
Shortage status Resolved
Updated date 2021-08-12
Company comments Product is on allocation at McKesson.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-08-12 French Compare
v6 2021-08-12 English Compare
v5 2019-08-16 French Compare
v4 2019-08-16 English Compare
v3 2019-07-09 English Compare
v2 2019-07-05 French Compare
v1 2019-07-05 English Compare

Showing 1 to 7 of 7